John H. Kenten
John H. Kenten publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology, on topics such as Monoclonal and Polyclonal Antibodies Research, Advanced biosensing and bioanalysis techniques and Glycosylation and Glycoproteins Research.
- World rank
- #1,393,213 of 7,710,434 ranked researchers
- Rank in United States
- #440,227 of 1,627,098
- Works
- 39
- Citations
- 2.5k
- Citations per work
- 65.0
What does John H. Kenten research?
John H. Kenten's work is mostly in Biochemistry, Genetics and Molecular Biology (59%), Medicine (23%), Engineering (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2359.0%
- Health Sciences923.0%
- Medicine923.0%
- Physical Sciences411.0%
- Engineering25.0%
- Environmental Science13.0%
- Materials Science13.0%
- Everything else37.0%
- 1Molecular Biology59% of their works
- 2Radiology, Nuclear Medicine and Imaging16% of their works
- 3Oncology7% of their works
- 4Biomedical Engineering5% of their works
- 5Ecology3% of their works
- 6Materials Chemistry3% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Advanced biosensing and bioanalysis techniques
- Glycosylation and Glycoproteins Research
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
- Protein purification and stability
- Cancer-related Molecular Pathways
- Advanced Biosensing Techniques and Applications
Which keywords describe John H. Kenten's research?
The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, DNA nanotechnology, Self-Assembly and Cancer.
- Protein Microarrays
- p53
- Ubiquitin
- Proteasome
- Translation
- Cancer Therapy
- Cancer
- DNA nanotechnology
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Self-Assembly
- Glycans
- Ribosome
- Biopharmaceuticals
- Protein Aggregation
- Cell Cycle
- High-Throughput Analysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Glycosylation262 topics
- Monoclonal Antibodies212 topics
- Therapeutic Antibodies212 topics
- Antibody Engineering161 topic
- Fc Receptors161 topic
- DNA nanotechnology121 topic
- Self-Assembly121 topic
- Cancer101 topic
- Glycans101 topic
- Cancer Therapy92 topics
- Ribosome81 topic
- Translation81 topic
- Biopharmaceuticals51 topic
- Proteasome51 topic
- Protein Aggregation51 topic
- Ubiquitin51 topic
- Cell Cycle41 topic
- p5341 topic
- High-Throughput Analysis31 topic
- Protein Microarrays31 topic
Where does John H. Kenten work?
John H. Kenten's main affiliation in the publication record is Meso Scale Discovery (United States), United States.
How many publications and citations does John H. Kenten have?
OpenAlex counts 39 works and 2,536 citations for John H. Kenten, an h-index of 19, ranking #1,393,213 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John H. Kenten. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.